Odey Asset Management Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Odey Asset Management Group’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-154,409	Closed	-$2.71M	–	74
2021 Q3	$2.71M	Buy	+154,409	New	+$1.8M	0.72%	38

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Odey Asset Management Group's TRIL Position: Q4 2021 in Review

Odey Asset Management Group sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 154,409 shares — an estimated $2.71M sold.

Odey Asset Management Group first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $2.71M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Odey Asset Management Group reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Odey Asset Management Group sold 154,409 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $2.71M.
Odey Asset Management Group first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Odey Asset Management Group's Trillium Therapeutics Inc. position peaked at $2.71M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Odey Asset Management Group's 13F filing for Q4 2021, filed 14 Feb 2022.